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 ABSTRACT  
 Objective: To examine the association between chronic hypertension (CH) and a wide 
range of adverse pregnancy outcomes after adjustment for confounding factors in 
obstetric history and maternal characteristics. 
 Methods: This was a prospective screening study for adverse pregnancy outcomes in 
women with singleton pregnancies attending the first routine hospital visit at 11+0-13+6 
weeks’ gestation. Data on maternal characteristics, medical and obstetric history and 
pregnancy outcomes were collected. Regression analysis was performed to examine the 
association between CH and adverse pregnancy outcomes including late miscarriage, 
stillbirth, pre-eclampsia (PE), gestational diabetes mellitus (GDM), spontaneous and 
iatrogenic preterm birth (PTB), small for gestational age (SGA) neonate, large for 
gestational age (LGA) neonate and elective and emergency cesarean  section (CS).  
 Results: The study population of 109,932 pregnancies included 1,417 (1.3%) with CH. 
After adjusting for potential confounding variables from maternal characteristics, medical 
and obstetric history, CH was associated with increased risk of stillbirth OR 2.38, 95% CI 
1.51-3.75), PE (OR 5.76, 95% CI 4.93-6.73), SGA (OR 2.06, 95% CI 1.79-2.39), GDM 
(OR 1.61, 95% CI 1.27-2.05), iatrogenic PTB <37 weeks (OR 3.73, 95% CI (3.07-4.53) 
and elective CS (OR 1.79, 95%CI 1.52-2.11), decreased risk of LGA (OR 0.65, 0.51-
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0.83), and had no significant effect on late miscarriage, spontaneous PTB or emergency 
CS. 
 
Conclusion: CH should be combined with other maternal characteristics and medical and 
obstetric history when calculating an individualised adjusted risk for adverse pregnancy 
complications. CH increases the risk for stillbirth, PE, SGA, GDM, iatrogenic PTB and 
elective CS and reduces the risk for LGA.  
 
 
Key Words: Chronic hypertension; preeclampsia; preterm birth; small for gestational age; 
large for gestational age; miscarriage, stillbirth, gestational diabetes; cesarean  section 
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Introduction 
 
Chronic hypertension (CH) is associated with increased risk for many pregnancy 
complications. A recent systematic review and meta-analysis of 55 studies 
encompassing 795,221 pregnancies reported that in women with CH the pooled 
incidences of superimposed preeclampsia (PE), preterm birth (PTB) at <37 weeks’ 
gestation, birth weight <2500 g and cesarean section (CS) were 26%, 20%, 17% and 
41%, respectively; compared to national averages the relative risks for CH were 7.7 for 
PE, 2.7 for PTB, 2.7 for birth weight <2500 g and 1.3 for CS.1 However, there was large 
heterogeneity between the included studies in the incidence of all outcomes and this is 
not surprising. First, the meta-analysis included a mixture of prospective and 
retrospective cohort studies and even randomised controlled trials, excluding the 
treatment arm if a difference existed in outcomes and including both arms if no benefit of 
the intervention was seen. Second, most of the data (>94%) were derived from a USA 
database on patients after hospitalization for delivery where outcomes were largely 
dependent on codes collected for billing purposes, which are susceptible to under 
ascertainment and misclassification bias.2 Third, the study period ranged between 1973 
and 2010, the studies differed in the inclusion or exclusion of multiple gestations and 
congenital abnormalities, in the definition of CH and in the definition of outcome 
measures; for example, in the case of superimposed PE 16 studies did not report 
diagnostic criteria and the remaining 39 studies used 18 different definitions, and fourth, 
most papers did not report relevant maternal characteristics precluding assessment of 
confounders. 
 
The aim of this prospective study of women recruited at the routine hospital visit at 11-13 
weeks’ gestation was to examine the association between CH and a wide range of well-
defined adverse pregnancy outcomes after adjustment for confounding factors in 
maternal characteristics, medical history and obstetric history. The rationale for such 
objective is to estimate the patient-specific risk for pregnancy complications as the basis 
for assessment of the value of therapeutic interventions aiming at their prevention. 
 
 
Methods 
 
Study population  
 
This was a prospective screening study for adverse obstetric outcomes in pregnant 
women attending for their first routine hospital visit at King’s College Hospital, London, 
UK (between March 2006 and July 2015) and Medway Maritime Hospital, Kent, UK 
(between February 2007 and November 2015). This visit, which was held at 11+0-13+6 
weeks of gestation, included recording of maternal demographic characteristics and 
obstetric and medical history, measurement of maternal weight and height, ultrasound 
examination for the measurement of the fetal crown-rump length (CRL) to determine 
gestational age,3 measurement of the fetal nuchal translucency thickness,4 and 
examination of the fetal anatomy for the diagnosis of major fetal defects.5  
 
Written informed consent was obtained from women who agreed to participate in the 
study, which was approved by the Ethics Committee of each participating Hospital. Data 
on pregnancy outcomes were collected from the hospital maternity records and the 
women’s general medical practitioners. 
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We excluded pregnancies with  fetal  aneuploidies  or  major  defects  diagnosed  either  
prenatally  or  in  the neonatal period, pregnancies ending in miscarriage at <16 weeks’ 
gestation and those ending in termination for psychosocial reasons. 
 
Maternal characteristics and obstetric history  
 
Participants completed a questionnaire on their age, racial origin (Caucasian,  Afro-
Caribbean,  South  Asian,  East  Asian  or  mixed), method of conception (spontaneous, 
in vitro fertilization or use of ovulation induction drugs), cigarette smoking during 
pregnancy, medical history of CH, diabetes mellitus (type 1 or 2), systemic lupus 
erythematosus (SLE) or antiphospholipid syndrome (APS), family history of PE (none or 
mother had PE), family history of diabetes mellitus (none or first or second degree 
relative) and obstetric history, including PE, GDM, stillbirth,  spontaneous and iatrogenic 
PTB, CS, miscarriage at 16+0- 23+6 weeks at any previous pregnancy and birth of small 
for gestational age (SGA) neonate with birth weight <10th percentile or large for 
gestational age (LGA) neonate with birth weight >90th percentile in the last pregnancy 
that delivered at >24 weeks’ gestation. The questionnaire was then reviewed by a doctor 
together with the woman and their weight and height were measured.  
 
Outcome measures 
 
Outcome measures included late miscarriage, stillbirth, PE, GDM, spontaneous and 
iatrogenic PTB, birth of SGA or LGA neonate, and delivery by elective or emergency CS. 
 
Late miscarriage included spontaneous delivery or fetal death at 16+0-23+6 weeks’ 
gestation. Stillbirths were fetal deaths at >24 weeks.  
 
The diagnosis of PE was made according to the guidelines of the International Society 
for the Study of Hypertension in Pregnancy.6 The systolic blood pressure should be >140 
mm Hg and/or the diastolic blood pressure should be >90 mmHg on at least two 
occasions four hours apart developing after 20 weeks’ gestation in a previously 
normotensive woman and in addition there should be significant proteinuria (>300 mg in 
24 hours, or two readings of at least ++ on dipstick analysis of midstream or catheter 
urine specimen, if no 24-hour collection is available). In CH diagnosis of superimposed 
PE requires the development of significant proteinuria after 20 weeks’ gestation in a 
previously non proteinuric woman. In the investigation of the relationship between CH 
and PE we excluded pregnancies ending in miscarriage. 
 
Screening for GDM was based on a two-step approach. In all women, random plasma 
glucose was measured at 24 - 28 weeks’ gestation and, if the concentration was >6.7 
mmol/L, an oral glucose tolerance test was carried out within two weeks. A diagnosis of 
GDM was made if the fasting plasma glucose level was >6 mmol/L or the plasma 
glucose level 2 hours after the oral administration of 75 g glucose was >7.8 mmol/L.7 In 
women with normal random blood glucose, an oral glucose tolerance test was performed 
if they had persistent glycosuria, developed polyhydramnios or the fetus became 
macrosomic. In the investigation of the relationship between CH and GDM we excluded 
pregnancies with pre-pregnancy diabetes mellitus and those ending in miscarriage or 
delivery before 30 weeks because they might not have had screening and diagnosis of 
GDM. 
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Preterm birth was divided into spontaneous and iatrogenic. Spontaneous PTB included 
those with spontaneous onset of labor and those with preterm prelabor rupture of 
membranes (PPROM) occurring at <37 and <34 weeks’ gestation. In the investigation of 
the relationship between CH and spontaneous PTB, we excluded pregnancies ending in 
miscarriage and those with iatrogenic PTB. In the investigation of the relationship 
between CH and iatrogenic PTB, we excluded pregnancies ending in miscarriage and 
those with spontaneous PTB.  
 
SGA and LGA neonates were defined as those with birth weight <5th and <10th percentile 
or above the 95th and 90th percentile for gestational age, respectively, without adjustment 
for maternal characteristics.8 In the investigation of the relationship between CH and 
SGA or LGA, we excluded pregnancies ending in miscarriage. 
 
Emergency CS included all cases where such delivery was undertaken after the onset of 
labor, usually for failure to progress, fetal distress or intrapartum hemorrhage. This group 
also included cases of antepartum hemorrhage requiring CS. Elective CS was performed 
before the onset of labor for obstetric or medical indications or at the request of the 
mother. In the investigation of the relationship between CH and emergency CS, we 
excluded pregnancies ending in miscarriage and those with elective CS. In the 
investigation of the relationship between CH and elective CS, we excluded pregnancies 
ending in miscarriage and those with emergency CS. 
 
Statistical Analysis  
 
Comparison of the maternal characteristics and obstetric history between pregnancies 
with and without CH was by the χ2-square test or Fisher’s exact test for categorical 
variables and Mann-Whitney U-test for continuous variables, respectively. Multivariable 
logistic regression analysis was performed to examine the effect of age, weight and 
racial origin on the incidence of CH in the study population.  
 
Univariable logistic regression analysis was performed to examine the association 
between CH and each of the adverse pregnancy outcomes. The risk for each of the 
pregnancy outcomes was then calculated from the formula: odds/(1 + odds), where odds 
= eY,  and  Y  was derived from the univariable logistic regression analysis. Multivariable 
logistic regression analysis was performed for the prediction of each pregnancy outcome 
from maternal age, weight, height, racial origin, mode of conception, smoking, medical 
history (CH, diabetes, SLE or APS), history of adverse outcome in a previous pregnancy 
(PE, GDM, late miscarriage, stillbirth, birth of SGA or LGA neonate, spontaneous or 
iatrogenic PTB and CS), and family history of PE or diabetes mellitus. Prior to performing 
the multivariable regression analysis, continuous variables were centered by subtracting 
the mean from each measured value (69 from maternal weight in kg, 164 from maternal 
height in centimeters and 30 from maternal age in years). In case of continuous 
variables, the association with each adverse outcome was assessed to determine 
whether the relationship was linear or non-linear by introducing linear, quadratic, and 
cubic terms in the regression model. If non-linear trends were significant they were 
introduced in the model as such, otherwise, linear terms were used.    
 
The statistical software package SPSS Statistics 20.0 (SPSS Inc., Chicago, Ill., USA) 
was used for data analyses.
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Results 
 
Study population  
 
A flow chart of study participants is shown in Figure 1. During the study period, first-
trimester combined screening for aneuploidies was carried out in 116,441 singleton 
pregnancies. We excluded from further analysis 6,509 (5.6%) women because there 
were no or incomplete data on pregnancy outcome (n=4,248), prenatal or postnatal 
diagnosis of aneuploidy or major defect or pregnancy termination for psychosocial 
reasons (n=1,999) and miscarriage at <16 weeks’ gestation (n=262).  
 
In the 109,932 pregnancies included in the study there were 1,417 (1.3%) who reported 
a medical history of CH. Maternal characteristics, medical history and previous obstetric 
history in those with and without CH are compared in Table 1. In the CH group there was 
a significantly higher age and weight and higher incidence of Afro-Caribbean racial 
origin, medical history of SLE or APS and diabetes mellitus, family history of PE and 
diabetes mellitus and previous obstetric history of late miscarriage, stillbirth, PE, GDM, 
SGA, LGA, spontaneous and iatrogenic PTB and CS. 
 
In the study population the incidence of CH increased exponentially with maternal age 
and weight (Figure 2) and compared to Caucasian women it was higher in those of Afro-
Caribbean racial origin (OR 3.03, 95% CI 2.71-3.39) and South Asian origin (1.93, 95% 
CI 1.46-2.54). 
 
Univariable logistic regression analysis demonstrated that CH was significantly 
associated with late miscarriage, stillbirth, PE, birth of SGA neonates, GDM, 
spontaneous and iatrogenic PTD and both elective and emergency CS, but not the  birth 
of LGA neonates (Table 2). The overall incidence of SGA neonates in patients with CH 
was twice as high as that in the group without CH, but the incidence of SGA in patients 
that developed PE was similar in those with or without CH. In the group that did not 
develop PE, the incidence of SGA was higher in those with than without CH. 
 
The results of multivariable logistic regression analysis for the prediction of pregnancy 
complications from maternal characteristics, medical history and previous obstetric 
history are summarized in Tables 3-11; CH provided significant independent contribution 
to stillbirth (OR 2.38, 95% CI 1.51-3.75), PE (OR 5.76, 95% CI 4.93-6.73), SGA <10th 
percentile (OR 2.06, 95% CI 1.79-2.39), LGA >90th percentile (OR 0.65, 0.51-0.83), 
GDM (OR 1.61, 95% CI 1.27-2.05), iatrogenic PTB <37 weeks (OR 3.73, 95% CI (3.07-
4.53) and elective CS (OR 1.79, 95% CI 1.52-2.11), but not late miscarriage, 
spontaneous PTB or emergency CS. 
 
In the stillbirths from the group with CH, compared to those without CH, the median 
gestational age at birth was lower [28.2, interquartile range (IQR) 26.1-32.7 weeks vs 
median 35.4, IQR 28.1-39.3 weeks; p=0.002] and there was a higher proportion with PE 
(59.1% vs 9.1%, p<0.0001), SGA <10th percentile (81.8% vs 39.1%, p<0.0001) and PE 
or SGA (90.9% vs 41.5%, p<0.001) (Figure 3).  
 
In the group without CH the mean birth weight z-score was 0.0 and one standard 
deviation was 1.1; the distribution of birth weight in the group with CH was shifted to the 
left with mean z-score of -0.22 and standard deviation of 1.2 (p<0.0001; Figure 4). 
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The incidence of iatrogenic PTB at <37 weeks was 12% in those with CH and 2% in 
those without CH. In the CH group the indications for iatrogenic delivery were fetal 
growth restriction, PE or fetal death in 79% (126/160) of cases and CH per se in 19 
(12%). In pregnancies without CH the indications for iatrogenic delivery were fetal growth 
restriction, PE or fetal death in 61% (1,236/2,033).  
 
Odds ratios, for the risk of pregnancy complications from CH, after adjustment for 
maternal characteristics, medical history and previous obstetric history, are shown in 
Figure 5. 
 
 
Discussion 
 
The incidence of CH increases with maternal age and weight and is three-times higher in 
women of Afro-Caribbean racial origin and twice as high in those of South Asian origin, 
compared to Caucasian women. In our multiracial inner city population the incidence of 
CH was 1.3%, but inevitably this rate will vary with the demographic characteristics of 
different study populations. Previous studies in non-pregnant populations have also 
documented that the incidence of CH increases with age and weight and is higher in 
Black than in White individuals.9,10  
 
Pregnancy in women with CH, after adjustment for other maternal characteristics, 
medical history and obstetric history, is associated with increased risk for a wide range of 
adverse pregnancy outcomes, including stillbirth, PE, SGA, GDM, iatrogenic PTB and 
elective CS, decreased risk for LGA, and does not have a significant effect on the 
incidence of late miscarriage, spontaneous PTB or emergency CS. 
 
In this study the patients were recruited at 11-13 weeks’ gestation when the fetuses were 
demonstrated to be alive and we therefore examined the rate of late rather than total 
miscarriage. Early miscarriages are often the consequence of severe chromosomal 
abnormalities, whereas the two most likely causes of late miscarriage are extreme 
placental impairment or extreme early spontaneous delivery of a fetus that dies during 
labor and / or delivery. We found that the incidence of late miscarriage was not 
significantly increased in pregnancies with CH.  
 
The risk of stillbirth in patients with CH, after adjustment for confounding factors, was 2.4 
times higher than in those without CH. This finding is compatible with the adjusted odds 
ratio of 2.6 observed in a systematic review and meta-analysis of 96 population-based 
studies in developed countries.11 The increased risk of stillbirth in patients with CH is 
likely to be the consequence of severe early onset impaired placental perfusion and 
function; in the CH group, compared to those without CH, the gestational age at stillbirth 
was substantially lower (28 vs 35 weeks) and the proportion with PE or SGA was much 
higher (91% vs 42%). In the group without CH many of the stillbirths in the UK are 
potentially avoidable if the current policy of antenatal monitoring by abdominal palpation 
or measurement of the symphysis-fundal height is replaced by routine ultrasound 
examination in the third trimester; most stillbirths in SGA fetuses occur after 32 weeks’ 
gestation and could be avoided by timely delivery. In contrast, stillbirths in the group of 
CH may be unavoidable because they occur early and the fetuses may be too small to 
be viable; 68% (15/22) of stillbirths in this study occurred at <29 weeks’ gestation and 
93% (14/15) of these were SGA. Strategies for prevention of stillbirth in pregnancies with 
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CH should focus on pharmacological interventions in early pregnancy to improve 
placentation. 
 
Superimposed PE complicated 23% of pregnancies with CH. The incidence of preterm 
PE was 8.5% and term PE 14.3% which could lead to the erroneous conclusion that CH 
is more closely associated with term rather than preterm PE. However, a higher 
incidence of term than preterm PE was also observed in pregnancies without PE (1.5% 
vs. 0.6%). After adjustment for confounding factors the risk of both preterm and term PE 
was 5-6 times higher in women with CH than in those without CH. We have previously 
reported the use of multivariate analysis to estimate the risk for PE from maternal 
characteristics and medical history and demonstrated that the strongest risk factor is 
CH.12 In our survival model for prediction of PE we proposed that all women will develop 
PE if pregnancy continued indefinitely and in a low-risk population the mean gestational 
age at delivery with PE is 55 weeks; in CH the distribution of delivery with PE is shifted 
to the left by eight weeks with a consequent increase in the incidence of both preterm 
and term PE.12 
 
In pregnancies with CH the incidence of SGA neonates was twice as high as in 
pregnancies without CH. It was previously suggested that such an association is the 
mere consequence of PE and that CH in the absence of PE does not increase the risk of 
SGA.13 We found that the incidence of SGA in patients that develop PE is considerably 
higher than in those without PE both in the CH group and in those without CH. However, 
even in the group of patients with CH that did not develop PE there was a 1.8-fold 
increase in the risk for SGA. Furthermore, in the CH group the distribution of birth weight 
adjusted for the gestational age at birth was Gaussian, rather than bimodal, and this was 
shifted to the left of the distribution of pregnancies without CH, suggesting that CH per 
se is associated with impaired placental perfusion and function. 
 
In the univariate analysis the incidence of LGA neonates was similar in those with and 
without CH. However, in the multivariate analysis, after adjustment for other factors in 
maternal characteristics, medical history and obstetric history, CH was associated with a 
highly significant reduction in the risk of LGA neonates reflecting the overall effect on 
shifting the distribution in birth weight to the left. 
 
In women with CH the incidence of GDM was substantially higher than in those without 
CH (8.1% vs. 2.3%). After adjusting for maternal age and weight, Afro-Caribbean, South 
Asian and East Asian racial origin, conception by the use of ovulation induction drugs, 
family history of diabetes mellitus and history of previous pregnancies affected by GDM 
and birth of LGA neonates, factors that are known to increase the risk of GDM,14 the 
odds ratio for GDM in pregnancies with CH was 1.6. The association between CH and 
GDM may be explained by the increased insulin resistance, chronic inflammation and 
endothelial dysfunction observed in both conditions.15,16 
 
Previous studies have documented an association between CH and increased rates of 
PTB and CS.1 Our study has clarified that after adjustment for confounding factors, CH 
was associated with a 3.7-fold increase in risk for iatrogenic PTB and 1.8-fold increase in 
risk for elective CS, without a significant effect on spontaneous PTB or emergency CS. 
Consequently, the association of CH with PTB is the result of medical intervention due to 
fetal growth restriction, PE or fetal death, which accounted for about 80% of iatrogenic 
PTBs, rather than CH per se being implicated in the pathogenesis of spontaneous onset 
of labor or PPROM. Similarly, the association with increased rate of CS is the 
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consequence of elective surgery rather than emergency CS for failure to progress or 
intrapartum fetal distress. 
 
The strengths of this study include first, prospective collection of data from a large inner 
city multiracial population, second, accurate assessment of gestational age and use of a 
wide range of well-defined adverse pregnancy outcomes, and third, application of 
multivariable logistic regression analysis to control for risk factors associated with each 
adverse outcome. The diagnosis of CH was based on the medical history obtained from 
women at the time of their hospital visit at 11-13 weeks and the incidence may therefore 
be underestimated, because we did not include cases where the diagnosis was made 
during the current pregnancy. A limitation of the study is that we did not examine the 
effect of baseline blood pressure or antihypertensive treatments on outcome but these 
are beyond the scope of the current investigation. 
 
In the proposed new pyramid of pregnancy care estimation of patient and disease 
specific risk for pregnancy complications and any possible therapeutic interventions 
should be undertaken at the 11-13 weeks hospital visit.17 The importance of screening 
for CH at the booking visit in pregnancy with subsequent increased antenatal 
surveillance is supported by the National Institute for Health and Clinical Excellence 
(NICE) in the UK.18 However, there is lack of national and/or international guidance on 
the management of CH in pregnancy. Future studies will determine whether the 
incidence of pregnancy complications in women with CH can be reduced by such 
measures as strict control of blood pressure or the use of aspirin or pravastatin soon 
after the 11-13 weeks visit. 
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Figure legends 
 
Figure 1. Flow chart of study participants. 
 
Figure 2. Relationship between maternal age and weight with the incidence of chronic 
hypertension. 
 
Figure 3. Birth weight and gestational age at birth of stillbirths from the chronic hypertension (CH) 
group (left) and those without CH (right). Closed circles are the cases with preeclampsia. 
 
Figure 4. Distribution of birth weight z-scores in pregnancies with chronic hypertension (red 
curve) and without chronic hypertension (blue curve). 
 
Figure 5. Forrest plot of odds ratios with 95% confidence intervals, for the risk of pregnancy 
complications from chronic hypertension, after adjustment for maternal characteristics, medical 
history and previous obstetric history. 
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Table 1. Maternal characteristics, medical and obstetric history in pregnancies with and without 
chronic hypertension.  
 
Maternal characteristics Chronic hypertension (n=1,417) 
No chronic hypertension 
(n=108,515) 
GA at recruitment (weeks), median (IQR) 12.7 (12.3-13.1) 12.7 (12.3-13.1) 
Age (years), median (IQR) 34.6 (30.7-38.4) ** 30.9 (26.3-34.9) 
Weight (kg), median (IQR) 81.5 (69.0-95.3) ** 66.5 (59.0-77.0) 
Height (cm), median (IQR) 164.4 (160.0-169.0) 164.3 (160.0-168.8) 
Racial origin   
     Caucasian, n (%) 731 (51.6) 82,066 (75.6) 
     Afro-Caribbean, n (%) 599 (42.3) ** 17,289 (15.9) 
     South Asian, n (%) 55 (3.9) 4,480 (4.1) 
     East Asian, n (%) 14 (1.0) * 2,080 (1.9) 
     Mixed, n (%) 18 (1.3) ** 2,600 (2.4) 
Method of conception   
     Spontaneous, n (%) 1,362 (96.1) 105,011 (96.8) 
     Ovulation drugs, n (%) 21 (1.5) 1,382 (1.3) 
     In vitro fertilization, n (%) 34 (2.4) 2,122 (2.0) 
Cigarette smoking, n (%) 101 (7.1) ** 11,551 (10.6) 
History of SLE / APS, n (%) 16 (1.1) ** 189 (0.2) 
History of diabetes mellitus   
     Type I, n (%) 20 (1.4) ** 450 (0.4) 
     Type II, n (%) 65 (4.6) ** 448 (0.4) 
Family history of PE 144 (10.2) ** 4,397 (4.1) 
Family history of diabetes mellitus   
     First degree, n (%) 267 (18.8) ** 12,958 (11.9) 
     Second degree, n (%) 95 (6.7) 8,535 (7.9) 
Obstetric history   
     Nulliparous, n (%) 454 (32.0) ** 50,969 (47.0) 
     Previous late miscarriage, n (%)  67 (4.7) ** 1,308 (1.2) 
     Previous stillbirth, n (%) 49 (3.5) ** 856 (0.8) 
     Previous PE, n (%) 312 (22.0) ** 3,318 (3.1) 
     Previous GDM, n (%) 50 (3.5) ** 1,534 (1.4) 
     Previous SGA <10th, n (%) 176 (12.4) ** 6,700 (6.2) 
     Previous LGA >90th, n (%) 134 (9.5) ** 6,193 (5.7) 
     Previous spontaneous PTB <37 w, n (%) 85 (6.0) ** 3,414 (3.1) 
     Previous iatrogenic PTB <37 w, n (%) 134 (9.5) ** 1,852 (1.7) 
     Previous CS, n (%) 343 (24.2) ** 13,499 (12.4) 
 
 
IQR = interquartile range; SLE = systemic lupus erythematosus; APS = antiphospholipid syndrome; PE = 
preeclampsia; GDM = gestational diabetes mellitus; SGA = birth weight <10th percentile; LGA = birth weight 
>10th percentile; PTB = preterm birth <37 weeks; CS = cesarean section 
 
*p<0.05 
**p<0.01
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Table 2. Univariate logistic regression analysis demonstrating the association of chronic 
hypertension with pregnancy complications  
 
Pregnancy complication Chronic hypertension 
No chronic 
hypertension OR (95% CI) P value 
Fetal loss   
      Late miscarriage, n/N (%) 29/1,417 (2.0) 776/108,515 (0.7) 2.56 (1.81 - 3.61) <0.0001 
      Stillbirth, n/N (%) 22/1,388 (1.6) 427/107,739 (0.4) 4.05 (2.63 - 6.23) <0.0001 
Preeclampsia   
      All, n/N (%) 286/1,388 (20.6) 2,274/107,739 (2.1) 12.0 (10.5 - 13.8) <0.0001 
     < 37 weeks, n/N (%) 102/1,204 (8.5) 614/106,079 (0.6) 15.9 (12.8 - 19.8) <0.0001 
     > 37 weeks, n/N (%) 184/1,286 (14.3) 1660/107,125 (1.5) 10.6 (9.0 - 12.5) <0.0001 
Small for gestational age   
     Birth weight <5th percentile, n/N (%) 159/1,388 (11.5) 5,945/107,739 (5.5) 2.22 (1.87 - 2.62) <0.0001 
          With preeclampsia, n/N (%) 62/286 (21.7) 434/2,274 (19.1) 1.17 (0.87 - 1.58) 0.296 
          Without preeclampsia, n/N (%) 97/1,102 (8.8) 5,511/105,465 (5.2) 1.75 (1.42 - 2.16) <0.0001 
     Birth weight <10th percentile, n/N (%) 267/1,388 (19.2) 11,768/107,739 (10.9) 1.94 (1.70 - 2.22) <0.0001 
          With preeclampsia, n/N (%) 87/286 (30.4) 648/2,274 (28.5) 1.10 (0.84 - 1.43) 0.498 
          Without preeclampsia, n/N (%) 180/1,102 (16.3) 11,120/105,465 (10.5) 1.66 (1.41 - 1.95) <0.0001 
Large for gestational age   
     Birth weight >90th percentile, n/N (%) 135/1,388 (9.7) 10,823/107,739 (10.0) 0.97 (0.81 - 1.15) 0.694 
     Birth weight >95th percentile, n/N (%) 82/1,388 (5.9) 6113/107,739 (5.7) 1.04 (0.83 - 1.31) 0.708 
Gestational diabetes mellitus, n/N (%) 104/1,284 (8.1) 2,438/106,504 (2.3) 3.50 (2.85-4.29) <0.0001 
Spontaneous preterm birth   
     < 34 weeks, n/N (%) 24/1,317 (1.8) 1,017/107,007 (1.0) 1.93 (1.29 - 2.91) 0.002 
     < 37 weeks, n/N (%) 54/1,224 (4.4) 3,882/105,579 (3.7) 1.21 (0.92 - 1.59) 0.175 
Iatrogenic preterm birth   
     < 34 weeks, n/N (%) 69/1,362 (5.1) 661/106,651 (0.6) 8.56 (6.64 - 11.03) <0.0001 
     < 37 weeks, n/N (%) 160/1,330 (12.0) 2,033/101,697 (2.0) 6.84 (5.77 - 8.12) <0.0001 
Cesarean section   
     Elective, n/N (%) 354/1,127 (31.4) 12,034/92,365 (13.0) 3.06 (2.69 - 3.47) <0.0001 
     Emergency, n/N (%) 261/1,034 (25.2) 15,374/95,705 (16.1) 1.76 (1.53-2.03) <0.0001 
 
 
    OR = odds ratio; CI = confidence interval 
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Table 3. Logistic regression analysis for the prediction of late miscarriage by maternal 
factors, medical history and obstetric history. 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome.  
 
Independent variable 
Miscarriage 
OR (95% CI) p 
(Maternal age in years – 30) 1.03 (1.01-1.04) <0.0001 
(Maternal weight in kg – 69) 1.01 (1.01-1.02) <0.0001 
(Maternal height in meters – 1.64) 0.98 (0.97-0.99) 0.004 
Racial origin   
   Caucasian (Reference) 1.00  
   Afro-Caribbean 3.34 (2.85-3.90) <0.0001 
   South Asian 1.67 (1.18-2.37) 0.004 
   East Asian 1.46 (0.85-2.51) 0.169 
   Mixed 2.39 (1.65-3.48) <0.0001 
Conception   
   Spontaneous (Reference) 1.00  
   Ovulation drugs 3.55 (2.47-5.10) <0.0001 
   In vitro fertilization 1.79 (1.19-2.69) 0.005 
Cigarette smoking 1.23 (0.97-1.57) 0.092 
History of chronic hypertension 1.33 (0.90-1.97) 0.158 
History of SLE / APS 0.76 (0.19-3.14) 0.706 
History of diabetes mellitus   
   None (Reference) 1.00  
   Type I  1.76 (1.78-3.99) 0.177 
   Type II  1.22 (0.64-2.35) 0.547 
Obstetric history   
   No previous pregnancy >16 weeks (Reference) 1.00  
   Pregnancies with late miscarriage 4.41 (3.34-5.82) <0.0001 
   Pregnancies without late miscarriage 0.86 (0.74-1.00) 0.053 
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Table 4. Logistic regression analysis for the prediction of stillbirth by maternal factors, 
medical history and obstetric history. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome.  
 
 
Independent variable 
Stillbirth 
OR (95% CI) p 
(Maternal age in years – 30) 1.00 (0.99-1.02) 0.736 
(Maternal weight in kg – 69) 1.01 (1.01-1.02) <0.0001 
(Maternal height in meters – 1.64) 0.98 (0.96-0.99) 0.006 
Racial origin   
   Caucasian (Reference) 1.00  
   Afro-Caribbean 2.14 (1.72-2.66) <0.0001 
   South Asian 1.23 (0.76-2.01) 0.404 
   East Asian 0.96 (0.42-2.17) 0.920 
   Mixed 1.26 (0.69-2.30) 0.459 
Conception   
   Spontaneous (Reference) 1.00  
   Ovulation drugs 2.02 (1.10-3.70) 0.023 
   In vitro fertilization 1.67 (0.94-2.95) 0.080 
Cigarette smoking 1.70 (1.29-2.23) <0.0001 
History of chronic hypertension 2.38 (1.51-3.75) <0.0001 
History of SLE / APS 0.78 (0.11-5.66) 0.806 
History of diabetes mellitus   
   None (Reference) 1.00  
   Type I  4.51 (2.30-8.85) <0.0001 
   Type II  1.84 (0.85-4.01) 0.123 
Obstetric history   
   Nulliparous (Reference) 1.00  
   Parous with previous stillbirth 3.94 (2.49-6.23) <0.000.1 
   Parous without previous stillbirth 0.74 (0.61-0.91) 0.003 
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Table 5. Logistic regression analysis for the prediction of all preeclampsia and 
preeclampsia with delivery at <37 and >37 weeks’ gestation by maternal factors, medical 
history and obstetric history.  
 
 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; SGA = small for gestational age. 
 
Independent variable 
All pre-eclampsia Pre-eclampsia at <37 w Pre-eclampsia at >37 w
OR (95% CI) p OR (95% CI) p OR (95% CI) p
(Maternal age in years - 30) 1.01 (1.00-1.02) 0.031 1.02 (1.00-1.03) 0.018 1.01 (1.00-1.02) 0.117 
(Maternal age in years - 30)2 1.00 (1.00-1.00) 0.001 - - - - 
(Maternal weight in kg - 69) 1.02 (1.01-1.02) <0.0001 1.02 (1.01-1.02) <0.0001 1.03 (1.02-1.04) <0.0001 
(Maternal weight in kg - 69)2 1.00 (1.00-1.00) <0.0001 - - 1.00 (1.00-1.00) <0.0001 
(Maternal height in cm - 164) 0.96 (0.96-0.97) <0.0001 0.96 (0.95-0.97) <0.0001 0.97 (0.96-0.98) <0.0001 
Racial origin       
   Caucasian (Reference) 1.00  1.00  1.00  
   Afro-Caribbean 2.16 (1.97-2.37) <0.0001 2.85 (2.41-3.37) <0.0001 1.95 (1.75-2.17) <0.0001 
   South Asian 1.39 (1.14-1.70) 0.001 1.68 (1.20-2.36) 0.003 1.24 (0.98-1.59) 0.078 
   East Asian 1.12 (0.81-1.56) 0.489 0.79 (0.39-1.60) 0.503 1.23 (0.85-1.78) 0.266 
   Mixed 1.07 (0.80-1.42) 0.668 1.38 (0.83-2.28) 0.213 0.97 (0.68-1.37) 0.849 
Conception       
   Spontaneous (Reference) 1.00  1.00  1.00  
   Ovulation drugs 1.03 (0.73-1.47) 0.851 1.71 (1.01-2.90) 0.047 0.81 (0.51-1.28) 0.370 
   In vitro fertilization 1.69 (1.35-2.11) <0.0001 2.35 (1.63-3.39) <0.0001 1.53 (1.17-2.00) 0.002 
Cigarette smoking 0.82 (0.70-0.95) 0.010 1.03 (0.78-1.36) 0.853 0.77 (0.64-0.93) 0.006 
History of chronic hypertension 5.76 (4.93-6.73) <0.0001 6.23 (4.83-8.04) <0.0001 5.41 (4.50-6.51) <0.0001 
History of SLE / APS 1.77 (0.96-3.24) 0.067 3.58 (1.61-7.94) 0.002 1.11 (0.47-2.61) 0.808 
History of diabetes mellitus       
   None (Reference) 1.00  1.00  1.00  
   Type I  1.62 (1.04-2.52) 0.033 3.51 (1.96-6.28) <0.0001 0.95 (0.50-1.82) 0.885 
   Type II  1.01 (0.67-1.52) 0.966 1.81 (1.04-3.13) 0.035 0.67 (0.39-1.17) 0.159 
Family history of preeclampsia 1.57 (1.34-1.83) <0.0001 1.77 (1.35-2.32) <0.0001 1.46 (1.21-1.75) <0.0001 
Obstetric history       
   Nulliparous (Reference) 1.00  1.00  1.00  
   Parous with previous preeclampsia 1.77 (1.54-2.03) <0.0001 2.11 (1.67-2.68) <0.0001 1.59 (1.35-1.87) <0.0001 
   Parous without previous preeclampsia  0.32 (0.29-0.36) <0.0001 0.34 (0.29-0.41) <0.0001 0.32 (0.28-0.36) <0.0001 
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Table 6. Logistic regression analysis for the prediction of small for gestational age 
neonates by maternal factors, medical history and obstetric history. 
 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; SGA = small for gestational age. 
 
* Logistic regression analysis after exclusion of cases of cases of SGA associated with 
preeclampsia demonstrated that there was still a significant contribution of chronic 
hypertension for prediction of both SGA <5th percentile (OR 1.82, 95% CI 1.46-2.28) and 
SGA <10th percentile (OR 1.81, 95% CI 1.53-2.15). 
Independent variable 
SGA <5th percentile SGA <10th percentile 
OR (95% CI) p OR (95% CI) p 
(Maternal age in years - 30) 1.01 (1.00-1.02) <0.0001 1.01 (1.00-1.01) <0.0001
(Maternal age in years - 30)2 1.00 (1.00-1.00) <0.0001 1.00 (1.00-1.00) <0.0001
(Maternal weight in kg – 69) 0.98 (0.98-0.98) <0.0001 0.99 (0.98-0.99) <0.0001
(Maternal weight in kg – 69)2 1.00 (1.00-1.00) <0.0001 1.00 (1.00-1.00) <0.0001
(Maternal height in cm – 164) 0.96 (0.95-0.96) <0.0001 0.96 (0.95-0.96) <0.0001
Racial origin    
   Caucasian (Reference) 1.00  1.00 
   Afro-Caribbean 2.27 (2.13-2.43) <0.0001 2.13 (2.02-2.24) <0.0001
   South Asian 2.10 (1.89-2.33) <0.0001 1.91 (1.76-2.07) <0.0001
   East Asian 1.24 (1.04-1.47) 0.015 1.07 (0.94-1.23) 0.307
   Mixed 1.52 (1.30-1.78) <0.0001 1.46 (1.30-1.65) <0.0001
Conception    
   Spontaneous (Reference) 1.00  1.00 
   Ovulation drugs 1.42 (1.15-1.76) 0.001 1.41 (1.20-1.65) <0.0001
    In vitro fertilization 1.00 (0.83-1.22) 0.976 1.02 (0.89-1.17) 0.776
Cigarette smoking 2.77 (2.58-2.98) <0.0001 2.46 (2.32-2.60) <0.0001
History of chronic hypertension* 2.23 (1.87-2.67) <0.0001 2.06 (1.79-2.39) <0.0001
History of SLE / APS 1.59 (0.95-2.67) 0.080 1.42 (0.94-2.15) 0.095
History of diabetes mellitus    
   None (Reference) 1.00  1.00 
   Type I  0.37 (0.19-0.72) 0.003 0.39 (0.25-0.62) <0.0001
   Type II  1.40 (1.00-1.96) 0.054 1.10 (0.83-1.46) 0.513
Obstetric history    
   Nulliparous (Reference) 1.00  1.00 
   Parous with previous SGA <10th  1.34 (1.23-1.46) <0.0001 1.42 (1.33-1.52) <0.0001
   Parous without previous SGA <10th 0.39 (0.37-0.42) <0.0001 0.41 (0.39-0.43) <0.0001
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Table 7. Logistic regression analysis for the prediction of large for gestational age 
neonates by maternal factors, medical history and obstetric history. 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; LGA = large for gestational age. 
 
Independent variable 
LGA >90th percentile LGA >95th percentile 
OR (95% CI) p OR (95% CI) p
(Maternal age in years - 30) 1.00 (0.99-1.00) 0.428 1.00 (0.99-1.00) 0.526
(Maternal weight in kg – 69) 1.04 (1.03-1.04) <0.0001 1.04 (1.04-1.04) <0.0001
(Maternal weight in kg – 69)2 1.00 (1.00-1.00) <0.0001 1.00 (1.00-1.00) <0.0001
(Maternal height in cm – 164) 1.03 (1.03-1.04) <0.0001 1.03 (1.03-1.04) <0.0001
Racial origin    
   Caucasian (Reference) 1.00  1.00 
   Afro-Caribbean 0.48 (0.45-0.52) <0.0001 0.52 (0.48-0.57) <0.0001
   South Asian 0.62 (0.54-0.72) <0.0001 0.64 (0.53-0.77) <0.0001
   East Asian 0.92 (0.77-1.11) 0.390 0.93 (0.73-1.20) 0.581
   Mixed 0.73 (0.63-0.85) <0.0001 0.74 (0.61-0.90) 0.003
Conception    
   Spontaneous (Reference) 1.00  1.00 
   Ovulation drugs 1.04 (0.87-1.24) 0.684 1.06 (0.84-1.33) 0.613
    In vitro fertilization 1.06 (0.91-1.23) 0.475 1.17 (0.96-1.41) 0.115
Cigarette smoking 0.46 (0.43-0.50) <0.0001 0.48 (0.43-0.54) <0.0001
History of chronic hypertension 0.65 (0.53-0.78) <0.0001 0.65 (0.51-0.83) <0.0001
History of SLE / APS 1.04 (0.67-1.62) 0.855 0.67 (0.34-1.29) 0.231
History of diabetes mellitus    
   None (Reference) 1.00  1.00 
   Type I  4.03 (3.27-4.97) <0.0001 4.99 (3.98-6.26) <0.0001
   Type II 1.61 (1.27-2.03) <0.0001 1.66 (1.26-2.18) <0.0001
Obstetric history    
   Nulliparous (Reference) 1.00  1.00 
   Parous with previous LGA >90th  5.65 (5.30-6.03) <0.0001 5.94 (5.50-6.42) <0.0001
   Parous without previous LGA >90th 1.38 (1.31-1.44) <0.0001 1.31 (1.23-1.40) <0.0001
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Table 8. Logistic regression analysis for the prediction of gestational diabetes mellitus by 
maternal factors, medical history and obstetric history. 
 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; LGA = large for gestational age; GDM = gestational diabetes mellitus. 
Independent variable 
Gestational diabetes mellitus 
OR (95% CI) p 
(Maternal age in years - 30) 1.07 (1.06-1.08) <0.0001 
(Maternal age in years - 30)2 1.00 (0.99-1.00) 0.009 
(Maternal weight in kg – 69) 1.05 (1.04-1.05) <0.0001 
(Maternal weight in kg – 69)2 1.00 (1.00-1.00) <0.0001 
(Maternal height in cm – 164) 0.95 (0.94-0.95) <0.0001 
Racial origin   
   Caucasian (Reference) 1.00  
   Afro-Caribbean 1.56 (1.40-1.74) <0.0001 
   South Asian 2.60 (2.21-3.07) <0.0001 
   East Asian 2.79 (2.20-3.54) <0.0001 
   Mixed 1.15 (0.86-1.54) 0.355 
Conception   
   Spontaneous (Reference) 1.00  
   Ovulation drugs 1.40 (1.02-1.92) 0.040 
    In vitro fertilization 1.23 (0.95-1.59) 0.122 
Cigarette smoking 0.87 (0.74-1.03) 0.113 
History of chronic hypertension 1.61 (1.27-2.05) <0.0001 
History of SLE / APS 0.26 (0.06-1.12) 0.071 
Family history of diabetes   
   First degree relative 2.48 (2.24-2.75) <0.0001 
   Second degree relative 1.89 (1.63-2.18) <0.0001 
Obstetric history   
   Nulliparous (Reference) 1.00  
   Parous with previous GDM 20.11 (17.57-23.02) <0.0001 
   Parous without previous GDM 0.45 (0.41-0.50) <0.0001 
   Parous with previous LGA >90th 1.80 (1.55-2.09) <0.0001 
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Table 9. Logistic regression analysis for the prediction of spontaneous preterm birth at 
<34 and <37 weeks’ gestation by maternal factors, medical history and obstetric history. 
 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = antiphospholipid 
syndrome; PTB = preterm birth. 
 
 
Independent variable 
Spontaneous preterm birth 
<34 w <37 w 
OR (95% CI) p OR (95% CI) p 
(Maternal age in years - 30) 1.01 (0.99-1.02) 0.108 1.00 (0.99-1.00) 0.471 
(Maternal weight in kg – 69) 1.00 (1.00-1.01) 0.180 1.00 (0.99-1.00) 0.008 
(Maternal weight in kg – 69)2 - - 1.00 (1.00-1.00) <0.0001
(Maternal height in cm –164) 0.98 (0.97-0.99) <0.0001 0.99 (0.98-0.99) <0.0001
Racial origin     
   Caucasian (Reference) 1.00  1.00  
   Afro-Caribbean 1.91 (1.65-2.23) <0.0001 1.23 (1.13-1.34) <0.0001
   South Asian 1.41 (1.06-1.89) 0.019 1.18 (1.01-1.38) 0.040 
   East Asian 1.00 (0.62-1.64) 0.990 0.94 (0.74-1.20) 0.627 
   Mixed 1.49 (1.04-2.13) 0.031 1.11 (0.90-1.36) 0.324 
Conception     
   Spontaneous (Reference) 1.00  1.00  
   Ovulation drugs 2.07 (1.37-3.12) 0.001 1.16 (0.88-1.53) 0.306 
    In vitro fertilization 1.87 (1.32-2.65) <0.0001 1.53 (1.25-1.87) <0.0001
Cigarette smoking 1.85 (1.56-2.20) <0.0001 1.53 (1.39-1.68) <0.0001
History of chronic hypertension 1.35 (0.88-2.07) 0.166 1.03 (0.78-1.37) 0.832 
History of SLE / APS 3.31 (1.53-7.18) 0.002 2.46 (1.47-4.11) 0.001 
History of diabetes mellitus     
   None (Reference) 1.00  1.00  
   Type I  4.36 (2.76-6.87) <0.0001 4.42 (3.30-5.92) <0.0001
   Type II  1.46 (0.76-2.80) 0.251 1.61 (1.10-2.38) 0.015 
Obstetric history     
   Nulliparous (Reference) 1.00  1.00  
   Parous with previous spontaneous birth <37 w 4.23 (3.52-5.08) <0.0001 4.47 (4.03-4.97) <0.0001
   Parous without previous spontaneous birth <37 w 0.55 (0.48-0.64) <0.0001 0.63 (0.58-0.68) <0.0001
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Table 10. Logistic regression analysis for the prediction of iatrogenic preterm birth at <34 
and <37 weeks’ gestation by maternal factors, medical history and obstetric history. 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; PTB = preterm birth. 
 
   
Independent variable 
Iatrogenic preterm birth 
<34 w <37 w 
OR (95% CI) p OR (95% CI) p 
(Maternal age in years - 30) 1.00 (0.99-1.02) 0.210 1.00 (0.99-1.01) 0.099
(Maternal weight in kg – 69) 1.01 (1.00-1.02) <0.0001 1.01 (1.00-1.01) <0.0001
(Maternal height in meters –1.64) 0.96 (0.95-0.97) <0.0001 0.97 (0.96-0.98) <0.0001
Racial origin    
   Caucasian (Reference) 1.00  1.00 
   Afro-Caribbean 1.89 (1.58-2.25) <0.0001 1.45 (1.30-1.62) <0.0001
   South Asian 1.23 (0.86-1.77) 0.267 1.14 (0.92-1.41) 0.248
   East Asian 1.32 (0.77-2.26) 0.320 0.81 (0.56-1.19) 0.288
   Mixed 1.60 (1.05-2.45) 0.029 1.16 (0.88-1.54) 0.283
Conception    
   Spontaneous (Reference) 1.00  1.00 
   Ovulation drugs 1.44 (0.82-2.53) 0.200 1.45 (1.04-2.02) 0.029
    In vitro fertilization 2.53 (1.76-3.65) <0.0001 2.17 (1.71-2.75) <0.0001
Cigarette smoking 1.70 (1.36-2.11) <0.0001 1.81 (1.60-2.05) <0.0001
History of chronic hypertension 4.30 (3.23-5.72) <0.0001 3.73 (3.07-4.53) <0.0001
History of SLE / APS 2.06 (0.81-5.27) 0.130 2.89 (1.66-5.04) <0.0001
History of diabetes mellitus    
   None (Reference) 1.00  1.00 
   Type I  4.32 (2.65-7.04) <0.0001 10.21 (7.85-13.26) <0.0001
   Type II  2.18 (1.21-3.72) 0.009 4.92 (3.69-6.56) <0.0001
Parity    
   Nulliparous (Reference) 1.00  1.00 
   Parous with previous iatrogenic birth <37 w 5.18 (4.09-6.54) <0.0001 6.35 (5.48-7.35) <0.0001
   Parous without previous iatrogenic birth <37 w 0.53 (0.44-0.62) <0.0001 0.67 (0.61-0.74) <0.0001
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Table 11. Logistic regression analysis for the prediction of elective and emergency 
cesarean  section by maternal factors, medical history and obstetric history. 
 
 
OR=odds ratio; CI=confidence interval; SLE = systemic lupus erythematosus; APS = 
antiphospholipid syndrome; CS = cesarean section. 
  
 
Independent variable 
Emergency cesarean section Elective cesarean section 
OR (95% CI) p OR (95% CI) p
(Maternal age in years - 30) 1.05 (1.05-1.06) <0.0001 1.06 (1.06-1.07) <0.0001
(Maternal age in years - 30)2 1.00 (0.99-1.00) <0.0001 - -
(Maternal weight in kg - 69) 1.02 (1.02-1.03) <0.0001 1.02 (1.01-1.02) <0.0001
(Maternal weight in kg - 69)2 1.00 (1.00-1.00) <0.0001 - -
(Maternal height in cm - 164) 0.94 (0.94-0.95) <0.0001 0.97 (0.96-0.97) <0.0001
Racial origin    
   Caucasian (Reference) 1.00  1.00 
   Afro-Caribbean 1.37 (1.31-1.44) <0.0001 0.84 (0.79-0.90) <0.0001
   South Asian 1.02 (0.93-1.11) 0.739 0.99 (0.89-1.11) 0.916
   East Asian 1.01 (0.88-1.15) 0.915 0.89 (0.75-1.05) 0.175
   Mixed 0.94 (0.83-1.07) 0.345 0.78 (0.66-0.91) 0.001
Conception    
   Spontaneous (Reference) 1.00  1.00 
   Ovulation drugs 0.98 (0.84-1.16) 0.836 1.18 (0.98-1.42) 0.081
    In vitro fertilization 1.24 (1.11-1.39) <0.0001 1.93 (1.69-2.20) <0.0001
Cigarette smoking 1.10 (1.03-1.18) 0.004 1.05 (0.97-1.13) 0.236
History of chronic hypertension 0.99 (0.85-1.17) 0.944 1.79 (1.52-2.11) <0.0001
History of SLE / APS 1.07 (0.71-1.62) 0.744 1.57 (1.02-2.40) 0.039
History of diabetes mellitus    
   None (Reference) 1.00  1.00 
   Type I  2.35 (1.84-3.01) <0.0001 4.35 (3.33-5.68) <0.0001
   Type II  1.09 (0.84-1.43) 0.517 2.00 (1.54-2.60) <0.0001
Obstetric history    
   Nulliparous (Reference) 1.00  1.00 
   Parous with previous CS 2.06 (1.95-2.18) <0.0001 12.80 (12.11-13.52) <0.0001
   Parous without previous CS 0.19 (0.18-0.20) <0.0001 0.53 (0.50-2.56) <0.0001
Onset of labor    
   Spontaneous (Reference) 1.00  - -
   Induced  2.42 (2.32-2.52) <0.0001 - -
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108,515 (98.7%)
did not have medical history of chronic hypertension
1,417 (1.3%)
had medical history of chronic hypertension
116,441 had screening for pregnancy complications at 11-13 weeks
6,509 (5.6%) were excluded:
4,248   Incomplete data on pregnancy outcome
1,802   Aneuploidy or major defect
197 Pregnancy termination for psychosocial reasons
262   Miscarriage at <16 weeks’ gestation    
109,932 included in the study
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Iatrogenic preterm birth
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Odds ratio with 95% confidence interval
Late miscarriage 1.33 (0.90-1.97)
Stillbirth 2.38 (1.51-3.75)
All 5.81 (4.97-6.79)
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<5th centile 2.35 (1.97-2.81)
Adverse outcome OR (95%CI)
≥37w 5.34 (4.44-6.43)
<10th centile 2.17 (1.88-2.50)
Large for gestational age
0.63 (0.50-0.81)
>95th centile 0.63 (0.52-0.76)
Gestational diabetes mellitus 1.57 (1.23-2.00)
<34w 1.35 (0.88-2.07)
<37w 1.06 (0.80-1.41)
<34w 4.30 (3.23-5.72)
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